External news, Forbes
External news
News Articles
-
-
External news, MedCity News
It’s Time to Evolve Beyond FMTs and Advance LBPs
-
External news, DCVC
With Assets from Federation Bio, Kanvas Aims to Replace Imprecise Microbiome Therapies with a Single, Rationally Designed Pill
-
External news, Fierce Biotech
As Federation folds, Kanvas Bio Picks Up the Pieces to Become Clinical-Stage Company
-
External news, DCVC
DCVC Leads $12M Financing for Kanvas Biosciences to Map the Human Body’s Undiscovered Territory: The Microbiome